Keywords rectal cancer radiation therapy organoids drug combination screen RAS signaling DNA repair radiosensitizer MEK inhibitor PARP inhibitor RAD51 Introduction Colorectal cancer (CRC) stands as a leading cause of cancer-related mortality.1 Over one-third of CRC originates in the rectum, often presenting at a locally advanced stage, which is defined as Union for International Cancer Control (UICC) classification T3/T4 (invasion beyond muscular layers) and/or node-positive disease.
Is this you? As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.
Claim your profile
Get in touch with Anna
Contact Anna, search articles and posts on X, monitor coverage, and track replies from one place.
Learn more about Muck Rack